Gooi, H.C. et al. Marker of peripheral blood granulocytes and monocytes of man recognized by two monoclonal antibodies VEP8 and VEP9 involves the trisaccharide 3-fucosyl-N-acetyllactosamine. Eur. J. Immunol. 13, 306–312 (1983).
Tao, W. et al. Comparative proteomic analysis of human CD34+ stem/progenitor cells and mature CD15+ myeloid cells. Stem Cells 22, 1003–1014 (2004).
Henderson, J.K. et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20, 329–337 (2002).
Anjos-Afonso, F. & Bonnet, D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 109, 1298–1306 (2007).
Gege, C., Geyer, A. & Schmidt, R.R. Synthesis and molecular tumbling properties of sialyl Lewis X and derived neoglycolipids. Chemistry 8, 2454–2463 (2002).
Foxall, C. et al. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide. J. Cell Biol. 117, 895–902 (1992).
Dimitroff, C.J., Bernacki, R.J. & Sackstein, R. Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood 101, 602–610 (2003).
Fuhlbrigge, R.C., Kieffer, J.D., Armerding, D. & Kupper, T.S. Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389, 978–981 (1997).
Sackstein, R. The bone marrow is akin to skin: HCELL and the biology of hematopoietic stem cell homing. J. Invest. Dermatol. 122, 1061–1069 (2004).
Sackstein, R. et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat. Med. 14, 181–187 (2008).
Zannettino, A.C. et al. Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood 85, 3466–3477 (1995).
Terstappen, L.W., Buescher, S., Nguyen, M. & Reading, C. Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry. Leukemia 6, 1001–1010 (1992).
van Gisbergen, K.P., Ludwig, I.S., Geijtenbeek, T.B. & van Kooyk, Y. Interactions of DC-SIGN with Mac-1 and CEACAM1 regulate contact between dendritic cells and neutrophils. FEBS Lett. 579, 6159–6168 (2005).
van Gisbergen, K.P., Sanchez-Hernandez, M., Geijtenbeek, T.B. & van Kooyk, Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 201, 1281–1292 (2005).
Kannagi, R. Transcriptional regulation of expression of carbohydrate ligands for cell adhesion molecules in the selectin family. Adv. Exp. Med. Biol. 491, 267–278 (2001).
Lowe, J.B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186, 19–36 (2002).
Nakayama, F. et al. CD15 expression in mature granulocytes is determined by alpha 1,3-fucosyltransferase IX, but in promyelocytes and monocytes by alpha 1,3-fucosyltransferase IV. J. Biol. Chem. 276, 16100–16106 (2001).
Lund-Johansen, F. & Terstappen, L.W. Differential surface expression of cell adhesion molecules during granulocyte maturation. J. Leukoc. Biol. 54, 47–55 (1993).
Kansas, G.S., Muirhead, M.J. & Dailey, M.O. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 76, 2483–2492 (1990).
Charrad, R.S. et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood 99, 290–299 (2002).
Gadhoum, Z. et al. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk. Lymphoma 45, 1501–1510 (2004).
Li, F. et al. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J. Biol. Chem. 271, 3255–3264 (1996).
Maemura, K. & Fukuda, M. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. J. Biol. Chem. 267, 24379–24386 (1992).
Fuhlbrigge, R.C., King, S.L., Sackstein, R. & Kupper, T.S. CD43 is a ligand for E-selectin on CLA+ human T cells. Blood 107, 1421–1426 (2006).
Fukushima, K. et al. Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res. 44, 5279–5285 (1984).
Datta, A.K. & Paulson, J.C. Sialylmotifs of sialyltransferases. Indian J. Biochem. Biophys. 34, 157–165 (1997).
Woods, J.M. et al. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob. Agents Chemother. 37, 1473–1479 (1993).
Stamatos, N.M. et al. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages. FEBS J. 272, 2545–2556 (2005).
Wang, P. et al. Induction of lysosomal and plasma membrane-bound sialidases in human T-cells via T-cell receptor. Biochem. J. 380, 425–433 (2004).
Azuma, Y., Taniguchi, A. & Matsumoto, K. Decrease in cell surface sialic acid in etoposide-treated Jurkat cells and the role of cell surface sialidase. Glycoconj. J. 17, 301–306 (2000).
Kopitz, J., Muhl, C., Ehemann, V., Lehmann, C. & Cantz, M. Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells. Eur. J. Cell Biol. 73, 1–9 (1997).
Monti, E. et al. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem. J. 349, 343–351 (2000).
Pshezhetsky, A.V. & Ashmarina, M. Lysosomal multienzyme complex: biochemistry, genetics, and molecular pathophysiology. Prog. Nucleic Acid Res. Mol. Biol. 69, 81–114 (2001).
Stroud, M.R. et al. Myeloglycan, a series of E-selectin-binding polylactosaminolipids found in normal human leukocytes and myelocytic leukemia HL60 cells. Biochem. Biophys. Res. Commun. 209, 777–787 (1995).
Dagia, N.M. et al. G-CSF induces E-selectin ligand expression on human myeloid cells. Nat. Med. 12, 1185–1190 (2006).
Hirata, T. et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for E-selectin in mediating T helper 1 lymphocyte migration. J. Exp. Med. 192, 1669–1676 (2000).
Levesque, J.P. et al. PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity 11, 369–378 (1999).
Varki, N.M. & Varki, A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab. Invest. 87, 851–857 (2007).
Cyopick, P. et al. Role of aberrant sialylation of chronic myeloid leukemia granulocytes on binding and signal transduction by chemotactic peptides and colony stimulating factors. Leuk. Lymphoma 11, 79–90 (1993).
Aldape, M.J., Bryant, A.E., Ma, Y. & Stevens, D.L. The leukemoid reaction in Clostridium sordellii infection: neuraminidase induction of promyelocytic cell proliferation. J. Infect. Dis. 195, 1838–1845 (2007).
Crocker, P.R. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr. Opin. Struct. Biol. 12, 609–615 (2002).
Nguyen, D.H., Ball, E.D. & Varki, A. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs. Exp. Hematol. 34, 728–735 (2006).
Capela, A. & Temple, S. LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev. Biol. 291, 300–313 (2006).
Da Silva, J.S., Hasegawa, T., Miyagi, T., Dotti, C.G. & Abad-Rodriguez, J. Asymmetric membrane ganglioside sialidase activity specifies axonal fate. Nat. Neurosci. 8, 606–615 (2005).